Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-003056

CEO and CFO bought 2,000 shares at $19.35 ($38,700)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2023-01-27 Purchase +2,000 $19.35 $38,700 2,734,886 D
Open-market purchases · 2,000 sh · avg $19.35 · $38,700
Loading xslF345X03/ownership.xml…